Sartorius AG Share Price
Stocks
SRT3
DE0007165631
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Xetra
16:35:08 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 251.40 EUR | +0.16% |
|
-5.24% | +1.70% |
| 10-01 | Sartorius AG : Goldman Sachs sticks Neutral | ZD |
| 09-30 | Sartorius AG : Barclays remains its Buy rating | ZD |
| Market Cap | 15.64B 17.61B 14.6B 13.31B 25.1B 1,693B 25.33B 177B 68.47B 865B 66.11B 64.67B 2,777B | P/E 2026 * |
66.3x | P/E 2027 * | 50.9x |
|---|---|---|---|---|---|
| Enterprise Value | 19.22B 21.63B 17.94B 16.35B 30.84B 2,079B 31.12B 217B 84.12B 1,063B 81.21B 79.45B 3,412B | EV / Sales 2026 * |
5.16x | EV / Sales 2027 * | 4.63x |
| Free-Float |
35.87% | Yield 2026 * |
0.32% | Yield 2027 * | 0.39% |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| SRT3 | Delayed | |
CBOE
| SRT3d | Real-time | |
|
Tradegate
| SRT3 | Real-time | |
|
London S.E.
| 0NIR | Delayed | |
|
CBOE
| 0NIR | Real-time | |
|
Börse Stuttgart
| SRT3 | Delayed | |
|
Boerse Muenchen
| SRT3 | Real-time | |
|
OTC Markets
| SUVPF | Delayed | |
|
Deutsche Boerse AG
| SRT3 | Delayed | |
|
Swiss Exchange
| SRT3 | Delayed | |
|
Wiener Boerse
| SRT3 | End-of-day quote | |
|
Borsa Italiana
| 1SRT3 | End-of-day quote |
Last Transcript: Sartorius AG
| 1 day | +0.16% | ||
| 1 week | -5.24% | ||
| Current month | -3.08% | ||
| 1 month | +1.70% | ||
| 3 months | +9.59% | ||
| 6 months | +18.64% | ||
| Current year | +1.70% |
| 1 week | 247 |  | 268.7 |
| 1 month | 226.2 | | 270 |
| Current year | 198.5 | | 270 |
| 1 year | 198.5 | | 270 |
| 3 years | 166.05 | | 383.7 |
| 5 years | 166.05 | | 631.6 |
| 10 years | 63.65 | | 631.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Grosse
CEO | Chief Executive Officer | 59 | 29/06/2025 |
Florian Funck
DFI | Director of Finance/CFO | 55 | 31/03/2024 |
Volker Niebel
COO | Chief Operating Officer | 70 | 31/12/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Annette Becker
BRD | Director/Board Member | 62 | 31/08/2002 |
Lothar Kappich
CHM | Chairman | 69 | 18/07/2017 |
| Director/Board Member | 77 | 28/11/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/05/26 | Free | Executive/Senior Manager | 4,268 | 0.0114% | ||
| 01/05/26 | Free | Executive/Senior Manager | 5,203 | 0.0139% | ||
| 12/03/26 | Buy | Chairman | 191 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | -5.24% | +15.75% | -21.88% | 17.52B | |
| +0.35% | -3.48% | +23.38% | +29.36% | 241B | |
| +1.09% | -4.34% | +0.55% | -13.72% | 149B | |
| -2.32% | -1.89% | -10.52% | +34.10% | 142B | |
| -1.46% | -4.66% | -55.56% | -19.32% | 62.65B | |
| -0.05% | -0.68% | +11.58% | +22.91% | 49.1B | |
| +0.66% | +1.75% | -18.23% | -21.12% | 47.13B | |
| +0.66% | -2.93% | +21.07% | +50.04% | 46.99B | |
| -3.05% | -0.55% | -6.80% | +34.35% | 45.65B | |
| -0.08% | -1.18% | +32.96% | +55.07% | 41.81B | |
| Average | -0.14% | -0.28% | +1.42% | +14.98% | 84.27B | |
| Weighted average by Cap. | +0.14% | +0.33% | +3.32% | +17.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.72B 4.19B 3.47B 3.17B 5.97B 403B 6.03B 42.05B 16.29B 206B 15.73B 15.39B 661B | 4.09B 4.6B 3.81B 3.48B 6.56B 442B 6.62B 46.15B 17.88B 226B 17.27B 16.89B 725B |
| Net income | 255M 287M 238M 217M 410M 27.62B 413M 2.88B 1.12B 14.12B 1.08B 1.06B 45.32B | 329M 371M 307M 280M 528M 35.63B 533M 3.72B 1.44B 18.22B 1.39B 1.36B 58.46B |
| Net Debt | 3.58B 4.02B 3.34B 3.04B 5.74B 387B 5.79B 40.38B 15.65B 198B 15.11B 14.78B 635B | 3.27B 3.68B 3.05B 2.78B 5.25B 354B 5.29B 36.93B 14.31B 181B 13.82B 13.52B 580B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | €251.40 | +0.16% | 103,977 |
| 01/10/26 | €251.00 | -3.24% | 82,247 |
| 30/09/26 | €259.40 | -0.23% | 143,697 |
| 29/09/26 | €260.00 | -1.33% | 67,052 |
| 28/09/26 | €263.50 | +2.01% | 103,766 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SRT3 Stock
Select your edition
All financial news and data tailored to specific country editions
